Testosterone Repletement: Is it the TRAVERSE Trial or a Travesty?

By sjmartinez • June 28, 2024

Budoff MJ. Testosterone Repletement: Is it the TRAVERSE Trial or a Travesty? JACC Adv. 2023 Nov 12;2(10):100742. doi: 10.1016/j.jacadv.2023.100742. PMID: 38938483; PMCID: PMC11198716.

Tags: Cardiology/Epi, clinical trials, Harbor UCLA, Hypogonadism, Publications, repletement, safety, testosterone

Cardiovascular Risks and Outcomes Among Chinese American Immigrants: Insights From the Multi-Ethnic Study of Atherosclerosis

Cai X, White Q, Wang DR, DeFilippi CR, Bertoni AG, Wu CO, Liu K, Lima JAC, Budoff MJ, Fonarow GC, Watson KE, McClelland RL, Yang[...]

Rural Hospital Performance in Guideline-Recommended Ischemic Stroke Thrombolysis, Secondary Prevention, and Outcomes

Man S, Bruckman D, Uchino K, Chen BY, Dalton JE, Fonarow GC. Rural Hospital Performance in Guideline-Recommended Ischemic Stroke Thrombolysis, Secondary Prevention, and Outcomes. Stroke.[...]

Diabetes, Functional Status, and Mortality in Chronic Heart Failure

Noumegni SR, Kaze AD, Bertoni AG, Fonarow GC, Echouffo-Tcheugui JB. Diabetes, Functional Status, and Mortality in Chronic Heart Failure. Diabetes Care. 2024 Sep 4:dc241586. doi:[...]